Key statistics
As of last trade, Pliant Therapeutics Inc (9PT:DUS) traded at 12.60, 36.22% above the 52 week low of 9.25 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.70 |
---|---|
High | 12.70 |
Low | 12.60 |
Bid | 12.50 |
Offer | 13.10 |
Previous close | 12.60 |
Average volume | 37.89 |
---|---|
Shares outstanding | 60.85m |
Free float | 59.06m |
P/E (TTM) | -- |
Market cap | 789.88m USD |
EPS (TTM) | -3.34 USD |
Data delayed at least 15 minutes, as of Nov 26 2024 08:31 GMT.
More ▼
Announcements
- Pliant Therapeutics to Participate in Upcoming Investor Events
- Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
- Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
- Pliant Therapeutics to Participate in the Stifel Healthcare Conference
- Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024
- Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
- Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024
- Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024
- Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
More ▼